United States

People: Depomed Inc (DEPO.O)

DEPO.O on Nasdaq

3:47pm EDT
Change (% chg)

$-0.08 (-1.25%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Dawes, Karen 

Ms. Karen A. Dawes is an Independent Director of Depomed, Inc. She has served as a director of the Company since April 2008. Since 2003, Ms. Dawes has served as President of Knowledgeable Decisions, LLC, a pharmaceutical consulting firm she founded. Between 1999 and 2003, Ms. Dawes served as Senior Vice President and U.S. Business Group Head for Bayer Corporation’s U.S. Pharmaceuticals Group. Prior to joining Bayer, she served as Senior Vice President, Global Strategic Marketing for Wyeth, formerly known as American Home Products, where she held responsibility for worldwide strategic marketing. She also served as Vice President, Commercial Operations for Genetics Institute, Inc., which was acquired by Wyeth in 1997. Ms. Dawes began her pharmaceutical industry career at Pfizer, Inc. where, from 1984 to 1994, she held a number of positions in Marketing, serving most recently as Vice President, Marketing of the Pratt Division. The Board considered Ms. Dawes’ experience and expertise within the following areas relevant to the Company and its business in concluding that she should serve on the Board: Marketing; Commercial Operations; Product Development; Commercial Strategy; Business Planning; Pharmaceutical Product Launch; Board Chair experience; and Compensation Committee experience. Ms. Dawes currently serves as a director of Repligen Corporation, a publicly-held bioprocess company, and several private companies. Ms. Dawes holds a M.B.A. from Harvard University and a B.A. and a M.A. from Simmons College.

Basic Compensation

Total Annual Compensation, USD 82,500
Restricted Stock Awards, USD 119,982
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 202,482

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --